Changes in Muscle Mass, Strength, and Muscle Protein Synthesis in Response to 5 Days of Bedrest in Young, Healthy Adults

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this intervention trial is to characterize skeletal muscle atrophy in healthy, young adults during short term bedrest. The main questions it aims to answer are: How much do skeletal muscle volume, strength, and fatigue resistance decline during bedrest? How much does whole-body insulin sensitivity change during bedrest? How do mitochondrial function and protein synthesis change during bedrest? Participants will undergo the following tests before and after a free-living control period and before and after a 5 day period of strict horizontal bedrest: * Magnetic resonance imaging of the thigh muscles * Strength testing of the thigh muscles * Insulin sensitivity testing in response to a mixed meal * Exogenous glucose oxidation in response to a mixed meal * Muscle biopsies from the thigh muscles * Blood samples

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 30
Healthy Volunteers: t
View:

• Males and females 18-30 years

• BMI between 18.5-28 kg/m2

• Weight stable (within ±2kg for 6 months)

• Generally healthy as assessed by medical and physical activity questionnaires

• recreationally active

Locations
Other Locations
Canada
Queen's Univeristy
RECRUITING
Kingston
Contact Information
Primary
Chris McGlory, PhD.
chris.mcglory@queensu.ca
6135336000
Time Frame
Start Date: 2025-09
Estimated Completion Date: 2027-06
Participants
Target number of participants: 12
Treatments
Experimental: Experimental: Bedrest
19 day study period, consisting of baseline testing, 5 days of free-living (habitual daily activities) immediately followed by 5 days of strict bedrest. Diet controlled and physical activity monitored for entire study period.
Related Therapeutic Areas
Sponsors
Collaborators: Canadian Institutes of Health Research (CIHR)
Leads: Queen's University

This content was sourced from clinicaltrials.gov